期刊文献+

Facile Approach to Synthesize Gold Nanorod@Polyacrylic Acid/Calcium Phosphate Yolk–Shell Nanoparticles for Dual-Mode Imaging and pH/NIR-Responsive Drug Delivery 被引量:3

Facile Approach to Synthesize Gold Nanorod@Polyacrylic Acid/Calcium Phosphate Yolk–Shell Nanoparticles for Dual-Mode Imaging and pH/NIR-Responsive Drug Delivery
下载PDF
导出
摘要 A facile strategy to fabricate gold nanorod@polyacrylic acid/calcium phosphate(Au NR@-PAA/Ca P) yolk–shell nanoparticles(NPs) composed with a PAA/Ca P shell and an Au NR yolk is reported. The asobtained Au NR@PAA/Ca P yolk–shell NPs possess ultrahigh doxorubicin(DOX) loading capability(1 mg DOX/mg NPs), superior photothermal conversion property(26%)and p H/near-infrared(NIR) dual-responsive drug delivery performance. The released DOX continuously increased due to the damage of the Ca P shell at low p H values. When the DOX-loaded Au NR@PAA/Ca P yolk–shell NPs wereexposed to NIR irradiation, a burst-like drug release occurs owing to the heat produced by the Au NRs. Furthermore,Au NR@PAA/Ca P yolk–shell NPs are successfully employed for synergic dual-mode X-ray computed tomography/photoacoustic imaging and chemo-photothermal cancer therapy. Therefore, this work brings new insights for the synthesis of multifunctional nanomaterials and extends theranostic applications. A facile strategy to fabricate gold nanorod@polyacrylic acid/calcium phosphate(Au NR@-PAA/Ca P) yolk–shell nanoparticles(NPs) composed with a PAA/Ca P shell and an Au NR yolk is reported. The asobtained Au NR@PAA/Ca P yolk–shell NPs possess ultrahigh doxorubicin(DOX) loading capability(1 mg DOX/mg NPs), superior photothermal conversion property(26%)and p H/near-infrared(NIR) dual-responsive drug delivery performance. The released DOX continuously increased due to the damage of the Ca P shell at low p H values. When the DOX-loaded Au NR@PAA/Ca P yolk–shell NPs wereexposed to NIR irradiation, a burst-like drug release occurs owing to the heat produced by the Au NRs. Furthermore,Au NR@PAA/Ca P yolk–shell NPs are successfully employed for synergic dual-mode X-ray computed tomography/photoacoustic imaging and chemo-photothermal cancer therapy. Therefore, this work brings new insights for the synthesis of multifunctional nanomaterials and extends theranostic applications.
出处 《Nano-Micro Letters》 SCIE EI CAS 2018年第1期63-73,共11页 纳微快报(英文版)
基金 the National Natural Science Foundation of China(Grant Nos.21573040 and 21603029) the Natural Science Foundation and Science and Technology Development Planning of Jilin Province(20150204086GX and20170520148JH) the Fundamental Research Funds for the Central Universities(2412016KJ007 and 2412016KJ020) the China Postdoctoral Science Foundation(2016M600224) the Jilin Provincial Research Foundation for Basic Research(20160519012JH) Jilin Provincial Key Laboratory of Advanced Energy Materials(Northeast Normal University)
关键词 Yolk–shell structure Calcium phosphate Dual-mode imaging Photothermal therapy Drug delivery Yolk–shell structure Calcium phosphate Dual-mode imaging Photothermal therapy Drug delivery
  • 相关文献

参考文献4

二级参考文献50

  • 1Eloubeidi, M. A.; Chen, V. K.; Eltoum, I. A.; Jhala, D.; Chhieng, D. C.; Jhala, N.; Vickers, S. M.; Wilcox, C. M. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: Diagnostic accuracy and acute and 30-day complications. Am. J. GastroenteroL 2003, 98, 2663-2668.
  • 2Vaccaro, V.; Sperduti, I.; Milella, M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 2011, 365, 768-769.
  • 3Wemer, J.; Combs, S. E.; Springfeld, C.; Hartwig, W.; Hackert, T.; Buchler, M. W. Advanced-stage pancreatic cancer: Therapy options. Nat. Rev. Clin. Oncol. 2013, 10, 323-333.
  • 4Von Hoff, D. D.; Ervin, T.; Arena, F. P.; Chiorean, E. G.; Infante, J.; Moore, M.; Seay, T.; Tjulandin, S. A.; Ma, W. W.; Saleh, M. N. et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 2013, 369, 1691-1703.
  • 5Cao, H.; Le, D.; Yang, L. X. Current status in chemotherapy for advanced pancreatic adenocarcinoma. Anticancer Res. 2013, 33, 1785-1791.
  • 6Bilimoria, K. Y.; Bentrem, D. J.; Ko, C. Y.; Stewart, A. K.; Winchester, D. P.; Talamonti, M. S. National failure to operate on early stage pancreatic cancer. Ann. Surg. 2007, 246, 173-180.
  • 7Kaur, S.; Baine, M. J.; Jain, M.; Sasson, A. R.; Batra, S. K. Early diagnosis of pancreatic cancer: Challenges and new developments. Biomark. Med. 2012, 6, 597-612.
  • 8Hosoki, T. Dynamic CT of pancreatic tumors. A JR Am. J. Roentgenol. 1983, 140, 959-965.
  • 9Sofuni, A.; Iijima, H.; Moriyasu, F.; Nakayama, D.; Shimizu, M.; Nakamura, K.; Itokawa, F.; Itoi, T. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J. Gastroenterol. 2005, 40, 518-525.
  • 10Dietrich, C. F.; Ignee, A.; Braden, B.; Barreiros, A. P.; Ott, M.; Hocke, M. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin. Gastroenterol. Hepatol. 2008, 6, 590-597, e591.

共引文献9

同被引文献15

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部